- Home
- RPRX vs HBAN Comparison
RPRX vs HBAN Comparison
Compare RPRX & HBAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RPRX | HBAN |
|---|---|---|
| Founded | 1996 | 1866 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.4B | 31.8B |
| IPO Year | 2020 | 2010 |
Fundamental Metrics
Financial Performance| Metric | RPRX | HBAN |
|---|---|---|
| Price | $66.77 | $16.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 21 |
| Target Price | ★ $65.38 | $18.78 |
| AVG Volume (30 Days) | 3.0M | ★ 23.4M |
| Earning Date | 11-04-2026 | 10-22-2026 |
| Dividend Yield | 1.40% | ★ 3.93% |
| EPS Growth | N/A | ★ 13.93 |
| EPS | 0.71 | ★ 0.92 |
| Revenue | ★ $2,378,193,000.00 | $1,562,000,000.00 |
| Revenue This Year | $47.40 | $35.12 |
| Revenue Next Year | $9.10 | $6.81 |
| P/E Ratio | $94.74 | ★ $17.11 |
| Revenue Growth | 5.06 | ★ 6.40 |
| 52 Week Low | $36.03 | $14.82 |
| 52 Week High | $67.71 | $19.44 |
Technical Indicators
Market Signals| Indicator | RPRX | HBAN |
|---|---|---|
| Relative Strength Index (RSI) | 73.14 | 57.86 |
| Support Level | $55.48 | $14.95 |
| Resistance Level | N/A | $17.25 |
| Average True Range (ATR) | 1.32 | 0.30 |
| MACD | 0.67 | 0.10 |
| Stochastic Oscillator | 90.98 | 92.47 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About HBAN Huntington Bancshares Incorporated
Huntington Bancshares is a regional US bank with over $280 billion in assets. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.